Developer of next-generation sequencing (NGS) technologies for the detection of microorganisms. The company's GENIUS software suite employs CosmosID’s curated genome database and utilizes proprietary algorithms to obtain, bacterial identification at the species, subspecies, and/or strain level. The company claims that the turnaround time is just a few minutes. The company was founded in 2008 and headquartered in Rockville, United States. It has raised $7.3M in series b funding, with backing from Plug and Play Tech Center, Applied Value Group, Business Innovation Network. The company operates in the Life Sciences - Life Sciences Platforms and Tools, Life Sciences - Genomics, Life Sciences - Clinical Genomics space. Its offerings span Genomics - Genomics Services - Full Service.
CosmosID
Series BDeveloper of next-generation sequencing (NGS) technologies for the detection of microorganisms. The company's GENIUS software suite employs CosmosID’s curated genome database and utilizes proprietary algorithms to obtain, bacterial identification at the species, subspecies, and/or strain level. The company claims that the turnaround time is just a few minutes. The company was founded in 2008 and headquartered in…
About
Business model
Genomics > Genomics Services > Full Service,
Life Sciences Platforms and Tools > Research Services > Genomics > Metagenomics,
Plug and Play Tech Center Batches > Food & Beverage > Batch 5
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ See who's investing in Life Sciences — full fund directory with check size and geography.